tiprankstipranks
Candel Therapeutics (CADL)
NASDAQ:CADL
US Market

Candel Therapeutics (CADL) Income Statement

Compare
303 Followers

Candel Therapeutics Income Statement

Last quarter (Q3 2024), Candel Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Candel Therapeutics's net income was $-10.65M. See Candel Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 125.00K$ 125.00K$ 125.00K
Gross Profit
$ 0.00$ -23.98M$ -862.00K$ -107.00K$ 125.00K
Operating Expenses
$ 33.37M$ 14.41M$ 34.80M$ 24.77M$ 13.31M
Depreciation and Amortization
$ 0.00$ 960.00K$ 987.00K$ 232.00K$ 91.00K
EBITDA
$ -33.37M$ -37.43M$ -17.32M$ -25.49M$ -13.72M
Operating Income
$ -33.37M$ -38.39M$ -34.72M$ -25.73M$ -13.81M
Other Income/Expenses
$ 0.00$ 452.00K$ 15.93M$ -10.40M$ -3.87M
Pretax Income
$ 0.00$ -37.94M$ -18.79M$ -36.12M$ -17.68M
Net Income
$ 0.00$ -37.94M$ -2.87M$ -36.18M$ -22.17M
Per Share Metrics
Basic EPS
$ -1.74$ -1.31$ -0.10$ -1.26$ -0.76
Diluted EPS
$ -1.74$ -1.31$ -0.10$ -1.26$ -0.76
Weighted Average Shares Outstanding
31.68M 28.94M 28.82M 28.69M 29.15M
Weighted Average Shares Outstanding (Diluted)
31.68M 28.94M 28.82M 28.69M 29.15M
Currency in USD

Candel Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis